Evidence map›Paper›PMID 36012678›Full record

ArticleInternational journal of molecular sciences2022

Heparan Sulfate Facilitates Binding of hIFN

Elisaveta Miladinova, Elena Lilkova, Elena Krachmarova, Kristina Malinova, Peicho Petkov, Nevena Ilieva, Genoveva Nacheva, Leandar Litov

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elisaveta MiladinovaFaculty of Physics, Sofia University "St. Kliment Ohridski", 5 James Bourchier Blvd., 1164 Sofia, Bulgaria.
Elena LilkovaInstitute of Information and Communication Technologies, Bulgarian Academy of Sciences, 2 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0003-2008-710X
Elena KrachmarovaInstitute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 21 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0002-9501-0724
Kristina MalinovaInstitute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 21 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria.
Peicho PetkovFaculty of Physics, Sofia University "St. Kliment Ohridski", 5 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-0420-9480
Nevena IlievaInstitute of Information and Communication Technologies, Bulgarian Academy of Sciences, 2 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0002-2372-2319
Genoveva NachevaInstitute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 21 Acad. G. Bonchev Str., 1113 Sofia, Bulgaria.ORCID 0000-0001-5663-8589
Leandar LitovFaculty of Physics, Sofia University "St. Kliment Ohridski", 5 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-8511-6883

Funding

Bulgarian Science Fund DN-11/20/2017Bulgarian Science Fund KP-06-DK1/5/2021 SARSSIM
6 · The paper itself

Abstract

Human interferon-gamma (hIFNγ) is a crucial signaling molecule with an important role in the initialization and development of the immune response of the host. However, its aberrant activity is also associated with the progression of a multitude of autoimmune and other diseases, which determines the need for effective inhibitors of its activity. The development of such treatments requires proper understanding of the interaction of hIFNγ to its cell-surface receptor hIFNGR1. Currently, there is no comprehensive model of the mechanism of this binding process. Here, we employ molecular dynamics simulations to study on a microscopic level the process of hIFNγ-hIFNGR1 complex formation in different scenarios. We find that the two molecules alone fail to form a stable complex, but the presence of heparan-sulfate-like oligosaccharides largely facilitates the process by both demobilizing the highly flexible C-termini of the cytokine and assisting in the proper positioning of its globule between the receptor subunits. An antiproliferative-activity assay on cells depleted from cell-surface heparan sulfate (HS) sulfation together with the phosphorylation levels of the signal transducer and activator of transcription STAT1 confirms qualitatively the simulation-based multistage complex-formation model. Our results reveal the key role of HS and its proteoglycans in all processes involving hIFNγ signalling.

Indexed as

Heparan SulfateProteoglycansCell MembraneHumansOligosaccharidesReceptors, Cell SurfaceHeparan SulfateOligosaccharidesProteoglycansReceptors, Cell Surfaceheparan sulfatehuman interferon gammahuman interferon gamma receptormolecular dynamics simulationssodium chlorate

Identifiers

PMID36012678
PMCPMC9408938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.